Sector
PharmaceuticalsOpen
₹1,765Prev. Close
₹1,752.3Turnover(Lac.)
₹4,410.98Day's High
₹1,809Day's Low
₹1,748.352 Week's High
₹2,03052 Week's Low
₹1,385.75Book Value
₹226.77Face Value
₹1Mkt Cap (₹ Cr.)
28,112.45P/E
43.04EPS
41.81Divi. Yield
0.863 Jul 2024
12:00 AM
AGM
Announcement Date: 03 Jul, 2024
22 Apr 2025
12:00 AM
Board Meeting
Agenda : Audited Result
4 Feb 2025
12:00 AM
Dividend
Dividend Amount: 8.5
Record Date: 08 Feb, 2025
The inspection was conducted from March 10 to March 13 of 2025 at Plot No. 5, GIDC, Panoli, Gujarat facility.
EBITDA at the operating level jumped 14.1% to ₹254.5 crore from ₹223.1 crore in the same quarter last year.
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 15.52 | 15.51 | 15.46 | 15.46 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 2,870.74 | 2,426.98 | 2,088.21 | 1,791 |
Net Worth | 2,886.26 | 2,442.49 | 2,103.67 | 1,806.46 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 2,189.87 | 1,891.99 | 1,640.74 | 1,250.13 |
yoy growth (%) | 15.74 | 15.31 | 31.24 | 6.42 |
Raw materials | -743.69 | -625.75 | -569.13 | -479.67 |
As % of sales | 33.96 | 33.07 | 34.68 | 38.36 |
Employee costs | -399.06 | -305.97 | -293.78 | -217.3 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 471.29 | 593.7 | 349.56 | 179.04 |
Depreciation | -71.28 | -67.35 | -65.09 | -55.94 |
Tax paid | -110.29 | -146.62 | -71.41 | -51.04 |
Working capital | 298.14 | 110.36 | 28.72 | 67.62 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 15.74 | 15.31 | 31.24 | 6.42 |
Op profit growth | -7.84 | 49.09 | 85.51 | -10.11 |
EBIT growth | -20.74 | 70.46 | 93.19 | -17.73 |
Net profit growth | -19.25 | 66.73 | 109.48 | -25.99 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 3,917.99 | 3,484.18 | 3,149.28 | 2,424.24 | 2,042.52 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 3,917.99 | 3,484.18 | 3,149.28 | 2,424.24 | 2,042.52 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 38.32 | 37.27 | 9.94 | 39.23 | 112.38 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Non-Exec. & Independent Dir.
Padmini Khare Kaicker
Non-Exec. & Independent Dir.
Sumit Bose
Non-Exec & Non-Independent Dir
Prashant Kumar.
Whole Time Director & CEO
Nikhil Chopra
Company Sec. & Compli. Officer
SANDEEP PHADNIS
Chairman & Independent Directo
Arun Duggal
Non Executive Director
GAURAV TREHAN
Non Executive Director
Akshay Tanna
Additional Director
Ashwani Puri
Neelam Centre 4th Floor,
B-Wing Hind Cycle Road Worli,
Maharashtra - 400030
Tel: 91-022-2482 2222/2493 0918
Website: http://www.jbpharma.com
Email: investorelations@jbpharma.com; secretarial@jbpharm
Plot No B-5 MIDC,
Part B Cross Lane, Marol Andheri(E),
Mumbai-400093
Tel: 91-22-6671 2151
Website: www.dfssl.com
Email: marketing@dfssl.com/investorsqry@dfssl.com
Summary
J B Chemicals & Pharmaceuticals Limited (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals on December 18, 1976. The Company is engaged i...
Read More
Reports by J B Chemicals & Pharmaceuticals Ltd
What is the J B Chemicals & Pharmaceuticals Ltd share price today?
What is the Market Cap of J B Chemicals & Pharmaceuticals Ltd?
What is the PE and PB ratio of J B Chemicals & Pharmaceuticals Ltd?
What is the 52 Week High and Low of J B Chemicals & Pharmaceuticals Ltd?
What is the CAGR of J B Chemicals & Pharmaceuticals Ltd?
What is the shareholding pattern of J B Chemicals & Pharmaceuticals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
